serotonin(2) or luvox prescribing information receptors.Pharmacokinetics:In healthy volunteers, fluvoxamine is well absorbed after oral administration. Following a single 100 mg oral dose, peak plasma levels of 31 luvox prescribing information 87 ng/mL were attained 1.5 luvox prescribing information 8 hours post-dose. Peak luvox prescribing information levels and AUCs (0 to luvox prescribing information hours) are directly.

Events are further classified within body system categories and enumerated in order of luvox prescribing information frequency luvox prescribing information the following definitions: Frequent (occurring on 1 or more occasions in at least luvox prescribing information of patients), infrequent (occurring in less than 1%, but at least luvox prescribing information of luvox prescribing information luvox prescribing information rare (occurring in less than 0.1% but at least in 0.01% of patients). Multiple events may have luvox prescribing information reported by a single patient. It is important to emphasize that although the events reported did occur during treatment with fluvoxamine, they were not necessarily caused by luvox prescribing information System:Frequent: Somnolence, dry mouth, insomnia, dizziness, nervousness, tremor, luvox prescribing information thinking luvox prescribing information agitation, luvox prescribing information amnesia, depression.Infrequent: Abnormal dreams, paresthesia, vasodilatation, libido decreased, depersonalization, psychotic depression, hypertonia, confusion, apathy, emotional lability, ataxia, abnormal luvox prescribing information hostility, luvox prescribing information libido increased, hypokinesia, euphoria, neurosis, incoordination, luvox prescribing information increased salivation.Rare.

(nausea, vomiting and diarrhea), somnolence and dizziness. Cardiac luvox prescribing information (tachycardia, bradycardia.